Last reviewed · How we verify
hemophilia B (congenital factor IX deficiency) with or without FIX inhibitors
Approved treatments
- Alhemo · Novo Nordisk Inc
Alhemo works by blocking the activation of blood clotting factors to prevent excessive bleeding in people with hemophilia.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- hemophilia B (congenital factor IX deficiency) with or without FIX inhibitors patent landscape — cliff calendar, originator estates, attackable patents
- hemophilia B (congenital factor IX deficiency) with or without FIX inhibitors treatment landscape brief
- hemophilia B (congenital factor IX deficiency) with or without FIX inhibitors treatment updates RSS
Frequently asked questions about hemophilia B (congenital factor IX deficiency) with or without FIX inhibitors
What drugs treat hemophilia B (congenital factor IX deficiency) with or without FIX inhibitors?
Tracked treatments include Alhemo.
What is the treatment for hemophilia B (congenital factor IX deficiency) with or without FIX inhibitors?
Standard treatment for hemophilia B (congenital factor IX deficiency) with or without FIX inhibitors includes Alhemo. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: hemophilia B (congenital factor IX deficiency) with or without FIX inhibitors patent cliff · hemophilia B (congenital factor IX deficiency) with or without FIX inhibitors CI report
- Treatment: Alhemo · Novo Nordisk Inc
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing